Our stories

Understanding the health risks of high LDL cholesterol

Reducing low-density lipoprotein (LDL) cholesterol may lower the risk of heart attacks and strokes

August 11, 2026

Our Q2 2026 financial results

August 4, 2026

From crosswords to cancer research

Rebecca Goldstein applies similar problem-solving and pattern-finding skills to immuno-oncology drug discovery that she uses to create crossword puzzles in her spare time

July 22, 2026

Understanding blood cancers

How MSD is helping advance research with new approaches for people living with these challenging conditions

June 10, 2026

MSD’s One Pipeline strategy: Purpose, patients and big bets on science

Our approach to drug development aims to bring together our own innovation with the best external science so we can more quickly help patients who are counting on us

June 8, 2026

What are individualized neoantigen therapies?

How scientists are harnessing the specific mutations of each person’s cancer to evaluate therapies that would be tailored to their own tumor

May 20, 2026

MSD and City Cancer Challenge expand global partnership to strengthen women’s cancer care

This initiative aims to reach more than 300,000 women living with cancer around the world by 2030

May 15, 2026